Buscador de publicacions

Publicacions

  • Chantada G.

    Retinoblastoma: Lessons and challenges from developing countries. Ellsworth Lecture 2011

    OPHTHALMIC GENETICS . 32(4): 196-203. Nº de cites: 20

    [doi:10.3109/13816810.2011.592173]

  • Chantada G, Qaddoumi I, Canturk S, Khetan V, Ma Z, Kimani K, Yeniad B, Sultan I, Sitorus RS, Tacyildiz N and Abramson DH.

    Strategies to Manage Retinoblastoma in Developing Countries

    PEDIATRIC BLOOD & CANCER . 56(3): 341-348. Nº de cites: 101

    [doi:10.1002/pbc.22843]

  • Scursoni AM, Galluzzo L, Camarero S, Lopez J, Lubieniecki F, Sampor C, Segatori VI, Gabri MR, Alonso DF, Chantada G and de Dávila MT.

    Detection of N-Glycolyl GM3 Ganglioside in Neuroectodermal Tumors by Immunohistochemistry: An Attractive Vaccine Target for Aggressive Pediatric Cancer

    CLINICAL & DEVELOPMENTAL IMMUNOLOGY . 2011: 245181-245181. Nº de cites: 42

    [doi:10.1155/2011/245181]

  • Canturk S, Qaddoumi I, Khetan V, Ma Z, Furmanchuk A, Antoneli CB, Sultan I, Kebudi R, Sharma T, Rodriguez-Galindo C, Abramson DH and Chantada G.

    Survival of retinoblastoma in less-developed countries impact of socioeconomic and health-related indicators

    BRITISH JOURNAL OF OPHTHALMOLOGY . 94(11): 1432-1436. Nº de cites: 141

    [doi:10.1136/bjo.2009.168062]

  • Dunkel IJ, Chan HS, Jubran R, Chantada G, Goldman S, Chintagumpala M, Khakoo Y and Abramson DH.

    High-Dose Chemotherapy With Autologous Hematopoietic Stem Cell Rescue for Stage 4B Retinoblastoma

    PEDIATRIC BLOOD & CANCER . 55(1): 149-152. Nº de cites: 42

    [doi:10.1002/pbc.22491]

  • Chantada G, Fandiño AC, Guitter MR, Raslawski EC, Dominguez JL, Manzitti J, de Dávila MT, Zubizarreta P and Scopinaro M.

    Results of a Prospective Study for the Treatment of Unilateral Retinoblastoma

    PEDIATRIC BLOOD & CANCER . 55(1): 60-66. Nº de cites: 43

    [doi:10.1002/pbc.22503]

  • Buitrago E, Höcht C, Chantada G, Fandiño A, Navo E, Abramson DH, Schaiquevich P and Bramuglia GF.

    Pharmacokinetic analysis of topotecan after intra-vitreal injection. Implications for retinoblastoma treatment

    EXPERIMENTAL EYE RESEARCH . 91(1): 9-14. Nº de cites: 32

    [doi:10.1016/j.exer.2010.03.009]

  • Carcaboso AM, Chiappetta DA, Opezzo JA, Höcht C, Fandiño AC, Croxatto JO, Rubio MC, Sosnik A, Abramson DH, Bramuglia GF and Chantada G.

    Episcleral Implants for Topotecan Delivery to the Posterior Segment of the Eye

    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE . 51(4): 2126-2134. Nº de cites: 42

    [doi:10.1167/iovs.09-4050]

  • Laurent VE, Otero LL, Vazquez V, Camarero S, Gabri MR, Labraga M, De Dávila MT, Chantada G and Alonso DF.

    Optimization of molecular detection of GD2 synthase mRNA in retinoblastoma

    MOLECULAR MEDICINE REPORTS . 3(2): 253-259. Nº de cites: 19

    [doi:10.3892/mmr_00000248]

  • Dunkel IJ, Jubran RF, Gururangan S, Chantada G, Finlay JL, Goldman S, Khakoo Y, O'Brien JM, Orjuela M, Rodriguez-Galindo C, Souweidane MM and Abramson DH.

    Trilateral Retinoblastoma: Potentially Curable With Intensive Chemotherapy

    PEDIATRIC BLOOD & CANCER . 54(3): 384-387. Nº de cites: 46

    [doi:10.1002/pbc.22336]